v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (7,398,666) $ (3,995,271)
Net income (loss) from discontinued operations (10,060) (31,992)
Net loss from continuing operations (7,388,606) (3,963,279)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 156,579 86,988
Interest expense - OID 625,546 121,080
Share based compensation, net 3,562
Loss on impairment of property and equipment 748,101
Changes in operating assets and liabilities:    
Accounts receivable 28,030 (41,700)
Prepaid expenses and other current assets (112,879) (115,584)
Accounts payable and accrued expenses 2,191,101 1,915,698
Net cash used in operating activities from continuing operations (3,752,128) (1,993,235)
Net cash used in operating activities from discontinued operations (10,060) (31,992)
Net cash used in operating activities (3,762,188) (2,025,227)
Cash flows from investing activities:    
Note receivable (375,000)
Net cash used in investing activities (375,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock 100,000
Proceeds from issuance of preferred stock, net of offering costs 975,951
Proceeds from notes payable 3,203,053 1,400,000
Payments on finance lease obligation (1,724)
Net cash provided in financing activities 3,303,053 2,374,227
Net decrease in cash (459,135) (26,000)
Cash, beginning of period 504,189 221,511
Cash, end of period 45,054 195,511
Non-cash investing and financial activities:    
Preferred stock conversion 4 2
Converted accrued C-1 dividends 29,000
Preferred dividends accrued – C-1 & C-2 217,000 210,000
Preferred dividends accrued – B-1 88,000
Preferred dividends accrued converted into C-1 & C-2 (178,000) (218,000)
Capitalized dividends – D, E F & G 3,512,000 1,588,000
Settlement of notes receivable in connection with asset purchase agreement $ 1,083,000